Dr. Matthew Giegengack, MD

  • Advance, NC
  • Ophthalmologist
NPI1437167350PAC ID2466458302
Medicare services, 2024
860
Medicare patients, 2024
474
Part D claims, 2024
1,520
Publications
6
Clinical trials
1
Practice address
329 Nc Highway 801 N, Bermuda Run, NC 27006
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Davie Surgery - Ophthalmology - HOPD

Acute Care Hospital outpatient department · Bermuda Run, North Carolina

Find Dr. Giegengack's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Matthew Giegengack is an ophthalmologist in Advance, North Carolina

Dr. Giegengack practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Giegengack's NPI, 1437167350, was assigned on August 4, 2006. Dr. Giegengack graduated from Columbia University College of Physicians and Surgeons in 2002. Dr. Giegengack holds North Carolina license 2007-01271.

NPI and contact details
Medicare PAC ID
2466458302
NPI enumeration date
August 4, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Matthew Giegengack practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina

Dr. Giegengack's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

  • Davie Surgery - Ophthalmology - HOPD
    329 Nc Highway 801 N, Bermuda Run, NC 27006

Source: Dmand AI Affiliation Data

Dr. Matthew Giegengack is affiliated with 2 sites of care and 1 medical group

Dr. Giegengack's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Giegengack is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist.

Davie Surgery - Ophthalmology - HOPDAcute Care Hospital outpatient department · Bermuda Run, North CarolinaPrimary
Atrium Health Wake Forest Baptist Medical CenterAcute care hospital, Winston Salem, NCAtrium Health Wake Forest BaptistPrimary care group, Winston Salem, NC

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Matthew Giegengack's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giegengack practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Davie Surgery - Ophthalmology - HOPDAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Giegengack practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Matthew Giegengack is one of 552 ophthalmologists in North Carolina

Ophthalmology is Dr. Giegengack's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Giegengack is licensed in North Carolina.

Specialties and state licenses

  • Ophthalmology, North CarolinaPrimaryLicense 2007-01271 · taxonomy 207W00000X

Ophthalmologists near Dr. Giegengack

Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Matthew Giegengack billed Medicare for 860 services in 2024

CMS data shows 860 Medicare services from Dr. Giegengack across 6 procedure codes in 2024, for 474 Medicare patients. Medicare paid $103,991 for them.

Medicare services, 2024860
Medicare patients474
Paid by Medicare$103,991
Procedure codes6

Dr. Giegengack's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6902024: 6752%
Surgery
2023: 1872024: 1851%

Where Dr. Giegengack's Medicare services took place, 2024

  • In an office40047%
  • In a facility46053%

Dr. Giegengack compared with the North Carolina median for ophthalmologists, 2024

  • Dr. Giegengack
  • North Carolina median
Medicare services
860vs 1,70149% below
Medicare patients
474vs 56616% below
Part D claims
1,442vs 6202.3 times

Medians across 580 ophthalmologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Giegengack's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Giegengack

Need commercial claims for Dr. Giegengack?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Giegengack and other ophthalmologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Matthew Giegengack treated 474 Medicare patients in 2024, average age 76

CMS counts 474 Medicare patients who saw Dr. Giegengack in 2024. The largest group is 75 to 84, with 197 patients. 74% of them have high cholesterol, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giegengack's median patient age at 75, with 64% women.

Medicare patients, 2024474
Average age76
Average risk score1.24
Also on Medicaid7%

Dr. Giegengack's Medicare patients by age, 2024

Dr. Giegengack's Medicare patients by sex, 2024

  • Women27859%
  • Men19641%

Chronic conditions among Dr. Giegengack's Medicare patients, 2024

  1. High cholesterol74%
  2. High blood pressure68%
  3. Arthritis45%
  4. Chronic kidney disease24%
  5. Anxiety23%
  6. Diabetes23%
  7. Mood disorders23%
  8. Osteoporosis23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Giegengack's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women64%
  • Men36%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Matthew Giegengack wrote 1,520 Medicare Part D claims in 2024

In 2024, Dr. Giegengack wrote 1,520 Medicare Part D claims for 481 patients. 38% of them were for generic drugs. CMS names the drug for 1,442 of them, across 17 drugs with 11 or more claims each, at $188,318 in total drug cost. In 2023, CMS named 1,330 claims across 18 drugs.

Part D claims, 20241,520
Drugs named by CMS17
Total drug cost$188,318
Part D patients481

Dr. Giegengack's Part D claims by kind of drug, 2024

  • Generic574 claims38%
  • Brand-name946 claims62%

Dr. Giegengack's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Giegengack's Part D claims, 2024

  • Antibiotics5%75 of 1,520 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,3302024: 1,4428%

Drugs named by CMS: 17 in 2024, 18 in 2023.

See all prescribing by Dr. Giegengack

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Matthew Giegengack ranks in the 78th percentile for cataract surgery in Medicare

Dr. Giegengack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 135 procedures of cataract surgery by Dr. Giegengack, more than 78% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Where Dr. Giegengack ranks in Medicare procedure volume

Cataract surgery
78th percentile135 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find ophthalmologists like Dr. Giegengack by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Matthew Giegengack has 6 publications on record

Dmand AI links 6 papers to Dr. Giegengack, published from 2011 to 2024. 2013 was the busiest year, with 2. The most frequent topics are Endothelium, Corneal, Cell Proliferation and Cells, Cultured. Dr. Giegengack has published most often in Biomed Mater. Dr. Giegengack's most frequent co-authors are Jeffrey Zane Kartchner, MD and Atalie Carina Thompson.

Papers6
Years published2011 to 2024

Dr. Giegengack's papers by year, 2011 to 2024

Topics Dr. Giegengack writes about most

  • Endothelium, Corneal
  • Cell Proliferation
  • Cells, Cultured
  • Endothelial Cells
  • Fibronectins
  • Limbus Corneae
  • Materials Testing
  • Tissue Scaffolds

Dr. Giegengack's most frequent co-authors

Recent publications by Dr. Giegengack

See all 6 publications and co-authors

See who Dr. Giegengack researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Giegengack works with, so you can find a warm path to the right ophthalmologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Matthew Giegengack has worked on 1 clinical trial

Dmand AI links Dr. Giegengack to 1 clinical trial. Conditions studied include Fuchs' Endothelial Dystrophy and Corneal Dystrophies, Hereditary.

Conditions in Dr. Giegengack's trials

  • Fuchs' Endothelial Dystrophy
  • Corneal Dystrophies, Hereditary

Recent clinical trials with Dr. Giegengack

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Matthew Giegengack received $4,934 in industry payments from 2016 to 2025

CMS Open Payments shows 61 general payments to Dr. Giegengack from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $3,703.

General payments to Dr. Giegengack by program year, 2016 to 2025

General payments to Dr. Giegengack by kind, 2016 to 2025

$4.9Kin total
  • Consulting fees$2,50051%
  • Food and beverage$2,19444%
  • Travel and lodging$1884%
  • Education$521%

Companies that paid Dr. Giegengack the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Giegengack

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Matthew Giegengack graduated from Columbia University College of Physicians and Surgeons

Dr. Giegengack graduated from Columbia University College of Physicians and Surgeons in 2002.

  1. Medical schoolColumbia University College of Physicians and Surgeons

Source: Dmand AI Professional Profile Data

Sources for Dr. Matthew Giegengack's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Matthew Giegengack

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Matthew Giegengack's NPI number?

Dr. Matthew Giegengack's NPI number is 1437167350. It was assigned on August 4, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Matthew Giegengack?

Dr. Matthew Giegengack is an ophthalmologist in Advance, North Carolina. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).

Where does Dr. Matthew Giegengack practice?

Dr. Giegengack practices at 329 Nc Highway 801 N, Bermuda Run, NC 27006. Dr. Giegengack's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

What is Dr. Matthew Giegengack's medical license number?

Dr. Giegengack holds North Carolina license 2007-01271.

Which hospitals is Dr. Matthew Giegengack affiliated with?

Dr. Giegengack is affiliated with Atrium Health Wake Forest Baptist Medical Center.

What medical group is Dr. Matthew Giegengack part of?

Dr. Giegengack is linked to Atrium Health Wake Forest Baptist.

Does Dr. Matthew Giegengack accept Medicare?

Yes. CMS data shows Dr. Giegengack billed Medicare for 860 services in 2024, and Dr. Giegengack accepts Medicare assignment.

How many Medicare patients does Dr. Matthew Giegengack see?

CMS counts 474 Medicare patients who saw Dr. Giegengack in 2024, with an average age of 76.

What services does Dr. Matthew Giegengack bill to Medicare?

In 2024, Dr. Giegengack's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and surgery: eye (66984).

Where did Dr. Matthew Giegengack go to medical school?

Dr. Giegengack graduated from Columbia University College of Physicians and Surgeons in 2002.

Show 5 more questionsShow fewer questions

What drugs does Dr. Matthew Giegengack prescribe most?

In 2024 Medicare Part D data, Dr. Giegengack's most prescribed drugs by claims were Prednisolone Acetate, Restasis and Moxifloxacin.

Has Dr. Matthew Giegengack received payments from drug or device companies?

CMS Open Payments shows $4,934 in general payments to Dr. Giegengack from 13 companies from 2016 to 2025. The largest total came from Johnson & Johnson Surgical Vision, Inc.

How long has Dr. Matthew Giegengack been practicing?

Dr. Giegengack graduated from medical school in 2002, 24 years ago.

Does Dr. Matthew Giegengack do research?

Dmand AI links 6 publications to Dr. Giegengack, published from 2011 to 2024. Dr. Giegengack has worked on 1 clinical trial.

Who does Dr. Matthew Giegengack publish with?

Dr. Giegengack's most frequent co-authors are Jeffrey Zane Kartchner, MD (1 shared paper) and Atalie Carina Thompson (1 shared paper).

Selling to ophthalmology practices?

See ophthalmologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)